Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study

BACKGROUND: The aim of this study was to evaluate disease-activity-guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis (AS) in a prospective, randomized, open-label, multicentric study. METHODS: Active AS patients with AS diseas...

詳細記述

保存先:
書誌詳細
出版年:Ther Adv Musculoskelet Dis
主要な著者: Zhang, Ting, Zhu, Jianing, He, Dongyi, Chen, Xiaowei, Wang, Hongzhi, Zhang, Ying, Xue, Qin, Liu, Weili, Xiang, Guangbo, Li, Yasong, Yu, Zhongming, Wu, Huaxiang
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7268122/
https://ncbi.nlm.nih.gov/pubmed/32536984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20929441
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料